{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:44:56Z","timestamp":1773801896399,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fujian Science and Technology Plan Project","award":["NO.2021D011, 2022D030"],"award-info":[{"award-number":["NO.2021D011, 2022D030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02205-w","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:20:45Z","timestamp":1773746445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ML364 ameliorates NLRP3-induced inflammatory response"],"prefix":"10.1007","volume":"75","author":[{"given":"Maoshu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengyue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roumei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changlong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daowei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"2205_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00276","volume":"10","author":"Y Zhen","year":"2019","unstructured":"Zhen Y, Zhang H. Nlrp3 inflammasome and inflammatory bowel disease. Front Immunol. 2019;10:276.","journal-title":"Front Immunol"},{"key":"2205_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00123","author":"W Tian","year":"2020","unstructured":"Tian W, Wang Z, Tang NN, Li JT, Liu Y, Chu WF, et al. Ascorbic acid sensitizes colorectal carcinoma to the cytotoxicity of arsenic trioxide via promoting reactive oxygen species-dependent apoptosis and pyroptosis. Front Pharmacol. 2020. https:\/\/doi.org\/10.3389\/fphar.2020.00123.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2205_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10753-019-01124-9","volume":"43","author":"LG Danielski","year":"2020","unstructured":"Danielski LG, Giustina AD, Bonfante S, Barichello T, Petronilho F. The NLRP3 inflammasome and its role in sepsis development. Inflammation. 2020;43(1):24\u201331.","journal-title":"Inflammation"},{"issue":"5","key":"2205_CR4","first-page":"48","volume":"120","author":"M Millerand","year":"2019","unstructured":"Millerand M, Berenbaum F, Jacques C. Danger signals and inflammaging in osteoarthritis. Clin Exp Rheumatol. 2019;120(5):48\u201356.","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"2205_CR5","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","volume":"122","author":"A Grebe","year":"2018","unstructured":"Grebe A, Hoss F, Latz E. Nlrp3 inflammasome and the IL-1 pathway in atherosclerosis. Circ Res. 2018;122(12):1722\u201340.","journal-title":"Circ Res"},{"issue":"8","key":"2205_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1089\/ars.2017.7313","volume":"29","author":"S Rovira-Llopis","year":"2018","unstructured":"Rovira-Llopis S, Apostolova N, Banuls C, Muntane J, Rocha M, Victor VM. Mitochondria, the NLRP3 inflammasome, and sirtuins in type 2 diabetes: new therapeutic targets. Antioxid Redox Signal. 2018;29(8):749\u201391.","journal-title":"Antioxid Redox Signal"},{"issue":"7-8","key":"2205_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41417-018-0062-x","volume":"27","author":"G Golinelli","year":"2020","unstructured":"Golinelli G, Grisendi G, Prapa M, Bestagno M, Spano C, Rossignoli F, et al. Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors. Cancer Gene Ther. 2020;27(7\u20138):558\u201370.","journal-title":"Cancer Gene Ther"},{"issue":"4","key":"2205_CR8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.hbpd.2021.04.013","volume":"20","author":"JL Pu","year":"2021","unstructured":"Pu JL, Huang ZT, Luo YH, Mou T, Li TT, Li ZT, et al. Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3beta\/AMPK\/NLRP3 inflammasome pathway. Hepatobiliary Pancreat Dis Int. 2021;20(4):352\u201360.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2205_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.coi.2020.10.011","volume":"68","author":"MT Milner","year":"2021","unstructured":"Milner MT, Maddugoda M, Gotz J, Burgener SS, Schroder K. The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer\u2019s disease. Curr Opin Immunol. 2021;68:116\u201324.","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"2205_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.hbpd.2023.11.006","volume":"23","author":"Q Huang","year":"2024","unstructured":"Huang Q, Liu JW, Dong HB, Wei ZJ, Liu JZ, Ren YT, et al. Mesenteric adipose tissue B lymphocytes promote intestinal injury in severe acute pancreatitis by mediating enteric pyroptosis. Hepatobiliary Pancreat Dis Int. 2024;23(3):300\u20139.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"5","key":"2205_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41419-020-2565-2","volume":"11","author":"B Hou","year":"2020","unstructured":"Hou B, Zhang Y, Liang P, He Y, Peng B, Liu W, et al. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype. Cell Death Dis. 2020;11(5):377.","journal-title":"Cell Death Dis"},{"issue":"11","key":"2205_CR12","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.molmed.2020.06.005","volume":"26","author":"M Rashidi","year":"2020","unstructured":"Rashidi M, Wicks IP, Vince JE. Inflammasomes and cell death: common pathways in microparticle diseases. Trends Mol Med. 2020;26(11):1003\u201320.","journal-title":"Trends Mol Med"},{"issue":"1","key":"2205_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1074\/jbc.C115.700492","volume":"291","author":"JL Schmid-Burgk","year":"2016","unstructured":"Schmid-Burgk JL, Chauhan D, Schmidt T, Ebert TS, Reinhardt J, Endl E, et al. A genome-wide CRISPR (clustered regularly interspaced short palindromic repeats) screen identifies NEK7 as an essential component of NLRP3 inflammasome activation. J Biol Chem. 2016;291(1):103\u20139.","journal-title":"J Biol Chem"},{"issue":"7761","key":"2205_CR14","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-019-1295-z","volume":"570","author":"H Sharif","year":"2019","unstructured":"Sharif H, Wang L, Wang WL, Magupalli VG, Andreeva L, Qiao Q, et al. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature. 2019;570(7761):338\u201343.","journal-title":"Nature"},{"key":"2205_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133328","author":"N Kelley","year":"2019","unstructured":"Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20133328.","journal-title":"Int J Mol Sci"},{"key":"2205_CR16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20182091","author":"J Tang","year":"2020","unstructured":"Tang J, Tu S, Lin G, Guo H, Yan C, Liu Q, et al. Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia. J Exp Med. 2020. https:\/\/doi.org\/10.1084\/jem.20182091.","journal-title":"J Exp Med"},{"issue":"2","key":"2205_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.molcel.2012.11.009","volume":"49","author":"BF Py","year":"2013","unstructured":"Py BF, Kim MS, Vakifahmetoglu-Norberg H, Yuan J. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol Cell. 2013;49(2):331\u20138.","journal-title":"Mol Cell"},{"key":"2205_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13727","volume":"7","author":"H Song","year":"2016","unstructured":"Song H, Liu B, Huai W, Yu Z, Wang W, Zhao J, et al. The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat Commun. 2016;7:13727.","journal-title":"Nat Commun"},{"key":"2205_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.741839","volume":"12","author":"T Tang","year":"2021","unstructured":"Tang T, Li P, Zhou X, Wang R, Fan X, Yang M, et al. The E3 ubiquitin ligase TRIM65 negatively regulates inflammasome activation through promoting ubiquitination of NLRP3. Front Immunol. 2021;12:741839.","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"2205_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Y Yan","year":"2015","unstructured":"Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z, et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell. 2015;160(1\u20132):62\u201373.","journal-title":"Cell"},{"issue":"1","key":"2205_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03669-z","volume":"9","author":"F Humphries","year":"2018","unstructured":"Humphries F, Bergin R, Jackson R, Delagic N, Wang B, Yang S, et al. The E3 ubiquitin ligase Pellino2 mediates priming of the NLRP3 inflammasome. Nat Commun. 2018;9(1):1560.","journal-title":"Nat Commun"},{"key":"2205_CR22","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201744766","author":"P Palazon-Riquelme","year":"2018","unstructured":"Palazon-Riquelme P, Worboys JD, Green J, Valera A, Martin-Sanchez F, Pellegrini C, et al. USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation. EMBO Rep. 2018. https:\/\/doi.org\/10.15252\/embr.201744766.","journal-title":"EMBO Rep"},{"issue":"5","key":"2205_CR23","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1080\/15548627.2021.1965426","volume":"18","author":"B Cai","year":"2022","unstructured":"Cai B, Zhao J, Zhang Y, Liu Y, Ma C, Yi F, et al. USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradation of NLRP3. Autophagy. 2022;18(5):990\u20131004.","journal-title":"Autophagy"},{"issue":"4","key":"2205_CR24","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41423-019-0237-x","volume":"17","author":"D Yang","year":"2020","unstructured":"Yang D, Liang Y, Zhao S, Ding Y, Zhuang Q, Shi Q, et al. ZBP1 mediates interferon-induced necroptosis. Cell Mol Immunol. 2020;17(4):356\u201368.","journal-title":"Cell Mol Immunol"},{"key":"2205_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106664","volume":"85","author":"J Wang","year":"2020","unstructured":"Wang J, Yang D, Shen X, Wang J, Liu X, Lin J, et al. BPTES inhibits anthrax lethal toxin-induced inflammatory response. Int Immunopharmacol. 2020;85:106664.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"2205_CR26","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.21037\/tcr.2020.02.17","volume":"9","author":"J Wang","year":"2020","unstructured":"Wang J, Zhan L, Cai Z, Liu X, Wang J, Zhong H, et al. Arsenic trioxide induces gasdermin E mediated pyroptosis in astroglioma cells. Transl Cancer Res. 2020;9(3):1926\u201330.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"2205_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-00869-x","volume":"8","author":"B Deng","year":"2022","unstructured":"Deng B, Yang D, Wu H, Wang L, Wu R, Zhu H, et al. Ketamine inhibits TNF-alpha-induced cecal damage by enhancing RIP1 ubiquitination to attenuate lethal SIRS. Cell Death Discov. 2022;8(1):72.","journal-title":"Cell Death Discov"},{"issue":"6","key":"2205_CR28","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41423-021-00683-y","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, He H, Lin B, Chen Y, Deng X, Jiang W, et al. RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor. Cell Mol Immunol. 2021;18(6):1425\u201336.","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"2205_CR29","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/jcmm.17128","volume":"26","author":"J Wang","year":"2022","unstructured":"Wang J, Peng X, Yang D, Guo M, Xu X, Yin F, et al. Bcl-2 hijacks the arsenic trioxide resistance in SH-SY5Y cells. J Cell Mol Med. 2022;26(2):563\u20139.","journal-title":"J Cell Mol Med"},{"issue":"31","key":"2205_CR30","doi-asserted-by":"publisher","first-page":"8705","DOI":"10.1073\/pnas.1524648113","volume":"113","author":"I Leung","year":"2016","unstructured":"Leung I, Dekel A, Shifman JM, Sidhu SS. Saturation scanning of ubiquitin variants reveals a common hot spot for binding to USP2 and USP21. Proc Natl Acad Sci U S A. 2016;113(31):8705\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"30","key":"2205_CR31","doi-asserted-by":"publisher","first-page":"48391","DOI":"10.18632\/oncotarget.10268","volume":"7","author":"T Wei","year":"2016","unstructured":"Wei T, Biskup E, Gjerdrum LM, Niazi O, Odum N, Gniadecki R. Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma. Oncotarget. 2016;7(30):48391\u2013400.","journal-title":"Oncotarget"},{"issue":"47","key":"2205_CR32","doi-asserted-by":"publisher","first-page":"24628","DOI":"10.1074\/jbc.M116.738567","volume":"291","author":"MI Davis","year":"2016","unstructured":"Davis MI, Pragani R, Fox JT, Shen M, Parmar K, Gaudiano EF, et al. Small molecule inhibition of the ubiquitin-specific protease USP2 accelerates cyclin D1 degradation and leads to cell cycle arrest in colorectal cancer and mantle cell lymphoma models. J Biol Chem. 2016;291(47):24628\u201340.","journal-title":"J Biol Chem"},{"issue":"2","key":"2205_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/JLB.MA0318-112RR","volume":"105","author":"D Bierschenk","year":"2019","unstructured":"Bierschenk D, Monteleone M, Moghaddas F, Baker PJ, Masters SL, Boucher D, et al. The Salmonella pathogenicity island-2 subverts human NLRP3 and NLRC4 inflammasome responses. J Leukoc Biol. 2019;105(2):401\u201310.","journal-title":"J Leukoc Biol"},{"issue":"50","key":"2205_CR34","doi-asserted-by":"publisher","first-page":"10075","DOI":"10.1021\/bi3009104","volume":"51","author":"WP Bozza","year":"2012","unstructured":"Bozza WP, Liang Q, Gong P, Zhuang Z. Transient kinetic analysis of USP2-catalyzed deubiquitination reveals a conformational rearrangement in the K48-linked diubiquitin substrate. Biochemistry. 2012;51(50):10075\u201386.","journal-title":"Biochemistry"},{"key":"2205_CR35","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3389\/fimmu.2016.00536","volume":"7","author":"S Zhao","year":"2016","unstructured":"Zhao S, Gong Z, Zhou J, Tian C, Gao Y, Xu C, et al. Deoxycholic acid triggers NLRP3 inflammasome activation and aggravates DSS-induced colitis in mice. Front Immunol. 2016;7:536.","journal-title":"Front Immunol"},{"issue":"3","key":"2205_CR36","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ, Higgins SC, Munoz-Planillo R, Inserra MC, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21(3):248\u201355.","journal-title":"Nat Med"},{"issue":"1","key":"2205_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04947-6","volume":"9","author":"H He","year":"2018","unstructured":"He H, Jiang H, Chen Y, Ye J, Wang A, Wang C, et al. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat Commun. 2018;9(1):2550.","journal-title":"Nat Commun"},{"issue":"10","key":"2205_CR38","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.4049\/jimmunol.2001178","volume":"206","author":"J Ni","year":"2021","unstructured":"Ni J, Guan C, Liu H, Huang X, Yue J, Xiang H, et al. Ubc13 promotes K63-linked polyubiquitination of NLRP3 to activate inflammasome. J Immunol. 2021;206(10):2376\u201385.","journal-title":"J Immunol"},{"issue":"1","key":"2205_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15314-8","volume":"7","author":"DW Shim","year":"2017","unstructured":"Shim DW, Shin WY, Yu SH, Kim BH, Ye SK, Koppula S, et al. BOT-4-one attenuates NLRP3 inflammasome activation: NLRP3 alkylation leading to the regulation of its ATPase activity and ubiquitination. Sci Rep. 2017;7(1):15020.","journal-title":"Sci Rep"},{"key":"2205_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.taap.2018.12.019","volume":"365","author":"H Chen","year":"2019","unstructured":"Chen H, Lin H, Xie S, Huang B, Qian Y, Chen K, et al. Myricetin inhibits NLRP3 inflammasome activation via reduction of ROS-dependent ubiquitination of ASC and promotion of ROS-independent NLRP3 ubiquitination. Toxicol Appl Pharmacol. 2019;365:19\u201329.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2205_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116275","volume":"268","author":"Y Tian","year":"2024","unstructured":"Tian Y, Liu K, Wu D, Wu L, Xu Q, Wei W, et al. The discovery of potent USP2\/USP8 dual-target inhibitors for the treatment of breast cancer via structure guided optimization of ML364. Eur J Med Chem. 2024;268:116275.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"2205_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59621-5","volume":"16","author":"P Dai","year":"2025","unstructured":"Dai P, Sun Y, Huang Z, Liu YT, Gao M, Liu HM, et al. USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity. Nat Commun. 2025;16(1):4564.","journal-title":"Nat Commun"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02205-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02205-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02205-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:03:56Z","timestamp":1773792236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02205-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2205"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02205-w","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"60"}}